The use of trazodone as a hypnotic: A critical review

Journal of Clinical Psychiatry

Volumn 65, Issue 6, 2004, Pages 752-755

  James, Steven P ^a,c,d   Mendelson, Wallace B ^b  

^a ELAN PHARMACEUTICALS   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c King Pharmaceuticals   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPNOTIC SEDATIVE AGENT; TRAZODONE;

ADDICTION; AGED; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; COMORBIDITY; DEPRESSION; HEART ARRHYTHMIA; HUMAN; INSOMNIA; MALE; PRIAPISM; REVIEW; SLEEP DISORDER; TREATMENT OUTCOME;

AGED; ARRHYTHMIA; CLINICAL TRIALS; COMORBIDITY; DEPRESSIVE DISORDER; HUMANS; HYPNOTICS AND SEDATIVES; MALE; PRIAPISM; SLEEP DISORDERS; SLEEP INITIATION AND MAINTENANCE DISORDERS; SUBSTANCE-RELATED DISORDERS; TRAZODONE; TREATMENT OUTCOME;

EID: 4344566387     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v65n0605     Document Type: Review

References (31)

1. Schweitzer PK, Walsh JK. Ten year trends in the pharmacologic treatment of insomnia [abstract]. Sleep 1998;21:247
2. Walsh JK. Epidemiology of insomnia treatment. Presented at the 41st meeting of the New Clinical Drug Evaluation Unit; May 28-31, 2001; Phoenix, Ariz
3. Johnson EO, Roehrs T, Roth T, et al. Epidemiology of alcohol and medication as aids to sleep in early adulthood. Sleep 1998;21:178-186 (Pubitemid 128470363)
4. Yamadera H, Nakamura S, Suzuki HES. Effects of trazodone hydrochloride and imipramine on polysomnography in healthy subjects. Psychiatry Clin Neurosci 1998;52:439-443 (Pubitemid 28412954)
5. Saletu-Zyhlarz GM, Abu-Bakr MH, Anderer P, et al. Insomnia in depression: differences in objective and subjective sleep and awakening quality to normal controls. Prog Neuropsychopharmacol Biol Psychiatry 2002;26:249-260
6. Van Bemmel AL, Beersma DG, van den Hoofdakker RH. Changes in EEG power density of non-REM sleep in depressed patients during treatment with trazodone. J Affect Disord 1995;35:11-19
7. Hertzberg MA, Feldman ME, Beckham JC, et al. Trial of trazodone for posttraumatic stress disorder using a multiple baseline group design. J Clin Psychopharmacol 1996;16:294-298 (Pubitemid 26254880)
8. Rickels K, Schweizer E, Garcia Espana F, et al. Trazodone and valproate in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal symptoms and taper outcome. Psychopharmacology (Berl) 1999;141:1-5 (Pubitemid 29193287)
9. Walsh JK, Erman M, Erwin CW, et al. Subjective hypnotic efficacy of trazodone and zolpidem in DSM-III-R primary insomnia. Hum Psychopharmacol 1998;13:191-198 (Pubitemid 28216251)
10. Saletu-Zyhlarz GM, Abu-Bakr MH, Anderer P, et al. Insomnia related to dysthymia: polysomnographic and psychometric comparison with normal controls and acute therapeutic trials with trazodone. Neuropsychobiology 2001;44:139-149 (Pubitemid 34701621)
11. Warner MD, Dorn MR, Peabody CA. Survey on the usefulness of trazodone in patients with PTSD with insomnia or nightmares. Pharmacopsychiatry 2001;34:128-131 (Pubitemid 32701761)
12. Costabile RA, Spevak M. Oral trazodone is not effective therapy for erectile dysfunction: a double-blind, placebo controlled trial. J Urol 1999;161:1819-1822 (Pubitemid 29420740)
13. van Moffaert M, de Wilde J, Vereecken A, et al. Mirtazapine is more effective than trazodone: a double-blind controlled study in hospitalized patients with major depression. Int Clin Psychopharmacol 1995;10:3-9
14. Enzlin P, Vanderschueren D, Bonte L, et al. Trazodone: a double-blind, placebo-controlled, randomized study of its effects in patients with erectile dysfunction without major organic findings. Int J Impot Res 2000;12:223-228 (Pubitemid 30807732)
15. Haria M, Fitton A, McTavish D. Trazodone: a review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders. Drugs Aging 1994;4:331-355 (Pubitemid 2065729)
16. Tummala R, Zajecka JM. Tricyclics: still solid performers for the savvy psychiatrist. Curr Psychiatry 2002;1:2-8
17. Fukunishi I, Kitaoka T, Shirai T, et al. A hemodialysis patient with trazodone-induced parkinsonism. Nephron 2002;90:222-223 (Pubitemid 34702002)
18. Aronson MD, Hafez H. A case of trazodone-induced ventricular tachycardia. J Clin Psychol 1986;47:388-389 (Pubitemid 16057616)
19. Janowsky D, Curtis G, Zisook S, et al. Ventricular arrhythmias possibly aggravated by trazodone. Am J Psychiatry 1983;140:796-797
20. Rausch JL, Pavlinac DM, Newman PE. Complete heart block following a single dose of trazodone. Am J Psychiatry 1984;141:1472-1473 (Pubitemid 14023958)
21. Himmelhoch JM, Schechtman K, Auchenbach R. The role of trazodone in the treatment of depressed cardiac patients. Psychopathology 1984;17(suppl 2):51-63 (Pubitemid 14148739)
22. Mazur A, Strasberg B, Kusniec J, et al. QT prolongation and polymorphous ventricular tachycardia associated with trazodone-amiodarone combination. Int J Cardiol 1995;52:27-29
23. Henry JA, Ali CJ, Caldwell R, et al. Acute trazodone poisoning: clinical signs and plasma concentrations. Psychopathology 1984;17(suppl 2):77-81 (Pubitemid 14148741)
24. de Meester A, Carbutti G, Gabriel L, et al. Fatal overdose with trazodone: case report and literature review. Acta Clin Belg 2001;56:258-261 (Pubitemid 32846924)
25. Maes M, Westenberg H, Vandoolaeghe E, et al. Effects of trazodone and fluoxetine in the treatment of major depression: therapeutic pharmacokinetic and pharmacodynamic interactions through formation of metachlorophenylpiperazine. J Clin Psychopharmacol 1997;17:258-364 (Pubitemid 27414391)
26. Haffmans PM, Vos MS. The effects of trazodone on sleep disturbances induced by brofaromine. Eur Psychiatry 1999;14:167-171 (Pubitemid 36187799)
27. Nierenberg AA, Adler LA, Peselow E, et al. Trazodone for antidepressant-associated insomnia. Am J Psychiatry 1994;151:1069-1072 (Pubitemid 24208646)
28. Patterson DE, Braverman SE, Belandres PV. Speech dysfunction due to trazodone-fluoxetine combination in traumatic brain injury. Brain Inj 1997;11:287-291 (Pubitemid 27153786)
29. Margolese H, Chouinard G. Serotonin syndrome from addition of low-dose trazodone to nefazodone [letter]. Am J Psychiatry 2000;157:1022 (Pubitemid 30412363)
30. Rush CR, Baker RW, Wright K. Acute behavioral effects and abuse potential of trazodone, zolpidem and triazolam in humans. Psychopharmacology (Berl) 1999;144:220-233 (Pubitemid 29307273)
31. Rush CR, Madakasira S, Hayes CA, et al. Trazodone and triazolam: acute subject-rated and performance-impairing effects in healthy volunteers. Psychopharmacology (Berl) 1997;131:9-18 (Pubitemid 27242849)